Stefania Pittaluga
#132,233
Most Influential Person Now
Researcher
Stefania Pittaluga's AcademicInfluence.com Rankings
Stefania Pittalugacomputer-science Degrees
Computer Science
#5867
World Rank
#6191
Historical Rank
Machine Learning
#1717
World Rank
#1740
Historical Rank
Artificial Intelligence
#1957
World Rank
#1991
Historical Rank
Database
#2989
World Rank
#3117
Historical Rank
Download Badge
Computer Science
Stefania Pittaluga's Degrees
- PhD Computer Science University of Milan
- Masters Computer Science University of Milan
Similar Degrees You Can Earn
Why Is Stefania Pittaluga Influential?
(Suggest an Edit or Addition)Stefania Pittaluga's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genetics and Pathogenesis of Diffuse Large B‐Cell Lymphoma (2018) (1081)
- Gene-expression profiles in hereditary breast cancer. (2001) (1045)
- Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma (2015) (879)
- The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. (2011) (789)
- Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics (2012) (766)
- Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. (2011) (553)
- Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency (2013) (534)
- Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. (2009) (531)
- Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4 (2014) (486)
- B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma (2013) (472)
- EBV Positive Mucocutaneous Ulcer—A Study of 26 Cases Associated With Various Sources of Immunosuppression (2010) (466)
- Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections (2010) (461)
- Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. (2013) (428)
- Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series (2020) (421)
- SARS-CoV-2 infection of the oral cavity and saliva (2021) (399)
- Diffuse Large B-cell Lymphomas With Plasmablastic Differentiation Represent a Heterogeneous Group of Disease Entities (2004) (387)
- Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. (2002) (372)
- Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial. (2015) (354)
- Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. (2003) (346)
- Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI (2017) (343)
- Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma. (2017) (341)
- Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study. (2015) (317)
- Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. (2010) (313)
- Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. (1988) (306)
- Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy. (2002) (294)
- Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. (2011) (287)
- Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers. (2008) (286)
- Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. (2008) (279)
- Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. (2006) (273)
- Mediastinal Gray Zone Lymphoma: The Missing Link Between Classic Hodgkin's Lymphoma and Mediastinal Large B-Cell Lymphoma (2005) (272)
- Low-intensity therapy in adults with Burkitt's lymphoma. (2013) (272)
- Mg2+ Regulates Cytotoxic Functions of NK and CD8 T Cells in Chronic EBV Infection Through NKG2D (2013) (254)
- An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease. (2010) (244)
- Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia. (2017) (242)
- Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. (2011) (233)
- A Multiprotein Supercomplex Controlling Oncogenic Signaling in Lymphoma (2018) (229)
- In situ localization of follicular lymphoma: description and analysis by laser capture microdissection. (2002) (225)
- Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma (2015) (223)
- EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment. (2015) (214)
- Ibrutinib inhibits BCR and NF-κB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL. (2014) (206)
- Oncogenic mechanisms in Burkitt lymphoma. (2014) (199)
- Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation. (2015) (196)
- Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas. (2000) (187)
- Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. (2014) (187)
- Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. (1996) (179)
- Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group. (1995) (177)
- The Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib (PCI-32765), Has Preferential Activity in the ABC Subtype of Relapsed/Refractory De Novo Diffuse Large B-Cell Lymphoma (DLBCL): Interim Results of a Multicenter, Open-Label, Phase 2 Study (2012) (175)
- The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma. (2010) (170)
- Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. (2003) (166)
- Congenital B cell lymphocytosis explained by novel germline CARD11 mutations (2012) (160)
- In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior (2012) (159)
- Metastasectomy for soft tissue sarcoma. Further evidence for efficacy and prognostic indicators. (1989) (157)
- A Pilot Study of CTLA-4 Blockade after Cancer Vaccine Failure in Patients with Advanced Malignancy (2007) (156)
- Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study. (2018) (153)
- Clonally related Histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: A study of 7 cases (2011) (148)
- Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma. (2011) (146)
- Selective generation of functional somatically mutated IgM+CD27+, but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease. (2006) (145)
- Mutations in PIK3CD Can Cause Hyper IgM Syndrome (HIGM) Associated with Increased Cancer Susceptibility (2014) (145)
- Clonality of angioimmunoblastic lymphadenopathy and implications for its evolution to malignant lymphoma. (1987) (144)
- The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. (1997) (143)
- Marginal Zone B-Cell Lymphoma in Children and Young Adults (2003) (143)
- The Causes of Death in Patients with Human Immunodeficiency Virus Infection: A Clinical and Pathologic Study with Emphasis on the Role of Pulmonary Diseases (1991) (141)
- Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications (2010) (140)
- The Genetic Basis of Hepatosplenic T-cell Lymphoma. (2017) (140)
- NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. (2011) (139)
- Chromothriptic Cure of WHIM Syndrome (2015) (139)
- Intracranial meningiomas following low-dose irradiation to the head. (1983) (138)
- Acute myeloid leukemia is associated with retroviral gene transfer to hematopoietic progenitor cells in a rhesus macaque. (2006) (138)
- Histologic Features of Sinus Histiocytosis With Massive Lymphadenopathy in Patients With Autoimmune Lymphoproliferative Syndrome (2005) (135)
- Multispectral imaging of clinically relevant cellular targets in tonsil and lymphoid tissue using semiconductor quantum dots (2006) (135)
- Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis. (2011) (133)
- ANX7, a candidate tumor suppressor gene for prostate cancer (2001) (133)
- Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization (1997) (130)
- Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome. (2010) (128)
- Atypical Pathologic Manifestations of Pneumocystis carinii Pneumonia in the Acquired Immune Deficiency Syndrome: Review of 123 Lung Biopsies from 76 Patients with Emphasis on Cysts, Vascular Invasion, Vasculitis, and Granulomas (1990) (127)
- Extrapulmonary Aspergillus infection in patients with CARD9 deficiency. (2016) (126)
- Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. (2013) (125)
- High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy. (2011) (123)
- Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma. (2016) (120)
- Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features (1996) (119)
- Cutaneous Lymphomatoid Granulomatosis: Correlation of Clinical and Biologic Features (2001) (119)
- Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin’s lymphoma and primary mediastinal large B-cell lymphoma (2011) (118)
- Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment (2008) (116)
- Follicular Lymphomas in Children and Young Adults: A Comparison of the Pediatric Variant With Usual Follicular Lymphoma (2013) (114)
- Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study. (2018) (113)
- Loss-of-function of the protein kinase C δ (PKCδ) causes a B-cell lymphoproliferative syndrome in humans. (2013) (113)
- Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations (2011) (113)
- A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor. (2014) (112)
- Trisomy 3 in marginal zone B‐cell lymphoma: a study based on cytogenetic analysis and fluorescence in situ hybridization (1996) (112)
- Current understanding of the role of Epstein–Barr virus in lymphomagenesis and therapeutic approaches to EBV-associated lymphomas (2008) (112)
- Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification. (2011) (112)
- SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation (2021) (111)
- Invasive aspergillosis due to Neosartorya udagawae. (2009) (110)
- Clonal Epstein-Barr Virus in Lymphoepithelioma-like Carcinoma of the Lung (1993) (109)
- Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS). (2016) (109)
- A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm. (2016) (107)
- Nonhepatosplenic &ggr;&dgr; T-cell Lymphomas Represent a Spectrum of Aggressive Cytotoxic T-cell Lymphomas With a Mainly Extranodal Presentation (2011) (106)
- Mantle cell lymphoma: a clinicopathological study of 55 cases (1995) (106)
- 3A1 (CD7) expression precedes T beta gene rearrangements in precursor T (lymphoblastic) neoplasms. (1986) (106)
- Increased expression of the PRAD‐1/CCND1 gene in hairy cell leukaemia (1995) (105)
- B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus–associated acute liver failure (2010) (105)
- CD55 Deficiency, Early‐Onset Protein‐Losing Enteropathy, and Thrombosis (2017) (105)
- Peripheral T-Cell Lymphomas Expressing CD30 and CD15 (2003) (104)
- Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications (2011) (101)
- Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques. (2007) (101)
- The Histological and Biological Spectrum of Diffuse Large B-Cell Lymphoma in the World Health Organization Classification (2012) (99)
- Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation. (2011) (99)
- Frequent STAT5B mutations in γδ hepatosplenic T-cell lymphomas (2014) (98)
- Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the Working Formulation. (1996) (97)
- Lymphomatoid Granulomatosis—A Single Institute Experience: Pathologic Findings and Clinical Correlations (2015) (97)
- Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls (2013) (94)
- Peripheral T-cell Lymphomas of Follicular T-Helper Cell Derivation With Hodgkin/Reed-Sternberg Cells of B-cell Lineage: Both EBV-positive and EBV-negative Variants Exist (2013) (94)
- Early lesions of follicular lymphoma: a genetic perspective (2014) (94)
- Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray (2004) (93)
- SARS-CoV-2 infection and persistence throughout the human body and brain (2021) (93)
- A prospective study of mediastinal gray-zone lymphoma. (2014) (93)
- Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy. (2012) (91)
- MDM2 Antagonist Nutlin-3 Displays Antiproliferative and Proapoptotic Activity in Mantle Cell Lymphoma (2009) (90)
- Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia (2009) (90)
- Multicentric Castleman disease: Where are we now? (2016) (89)
- Mutation analysis of the rearranged immunoglobulin heavy chain genes of marginal zone cell lymphomas indicates an origin from different marginal zone B lymphocyte subsets. (1998) (89)
- A subset of Rosai–Dorfman disease cases show increased IgG4‐positive plasma cells: another red herring or a true association with IgG4‐related disease? (2014) (87)
- Interleukin-12 receptor β1 deficiency predisposing to disseminated Coccidioidomycosis. (2011) (86)
- Modeling Tumor-Host Interactions of Chronic Lymphocytic Leukemia in Xenografted Mice to Study Tumor Biology and Evaluate Targeted Therapy (2013) (85)
- Serum viral interleukin-6 in AIDS-related multicentric Castleman disease. (2001) (83)
- T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Heterogeneous Entity With Derivation From Germinal Center B Cells (2002) (83)
- Hypomorphic Rag mutations can cause destructive midline granulomatous disease. (2010) (83)
- Diagnosis of Hodgkin lymphoma in the modern era (2018) (82)
- A pilot study of cidofovir in patients with kaposi sarcoma. (2003) (81)
- Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease. (2014) (79)
- Path to the clinic: assessment of iPSC-based cell therapies in vivo in a nonhuman primate model. (2014) (79)
- Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma (2019) (78)
- The clinical outcome of 65 cases of mantle cell lymphoma initially treated with non‐intensive therapy by the British National Lymphoma Investigation Group (1997) (76)
- Insights into pathogenesis of fatal COVID‐19 pneumonia from histopathology with immunohistochemical and viral RNA studies (2020) (75)
- "Small" B-cell non-Hodgkin's lymphomas with splenomegaly at presentation are either mantle cell lymphoma or marginal zone cell lymphoma. A study based on histology, cytology, immunohistochemistry, and cytogenetic analysis. (1996) (74)
- Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation. (2008) (73)
- A novel role for IL-22R1 as a driver of inflammation. (2011) (72)
- Platelets contribute to disease severity in COVID‐19 (2021) (71)
- SARS-CoV-2 infection and persistence in the human body and brain at autopsy (2022) (71)
- The VEGF inhibitor axitinib has limited effectiveness as a therapy for adrenocortical cancer. (2014) (71)
- Viral, immunologic, and clinical features of primary effusion lymphoma. (2019) (70)
- Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases (2011) (70)
- Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival. (2012) (70)
- Clonal T-cell Populations and Increased Risk for Cytotoxic T-cell Lymphomas in B-CLL Patients: Clinicopathologic Observations and Molecular Analysis (2004) (70)
- Primary low-grade B-cell lymphoma of MALT-type occurring in the liver: a study of two cases. (1997) (69)
- Secondary chromosome changes in mantle cell lymphoma. (1999) (68)
- Analysis of expressed immunoglobulin heavy chain genes in familial B-CLL. (2000) (67)
- Molecular characterization of the t(2;5) (p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease. (1996) (67)
- Highly Variable Clinical Phenotypes of Hypomorphic RAG1 Mutations (2010) (67)
- Molecular Profiling Provides Evidence of Primary Mediastinal Large B-Cell Lymphoma as a Distinct Entity Related to Classic Hodgkin Lymphoma: Implications for Mediastinal Gray Zone Lymphomas as an Intermediate Form of B-Cell Lymphoma (2004) (67)
- Immunoblastic Lymphoma in Persons with AIDS-Associated Kaposi's Sarcoma: a Role for Kaposi's Sarcoma–Associated Herpesvirus (2003) (65)
- Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion. (2016) (65)
- Pathologic findings associated with interleukin-2-based immunotherapy for cancer: a postmortem study of 19 patients. (1990) (65)
- T-cell/histiocyte-rich large B-cell lymphoma (2010) (64)
- IgD Positive L&H Cells Identify a Unique Subset of Nodular Lymphocyte Predominant Hodgkin Lymphoma (2006) (63)
- Mutations in the JAK/STAT and RAS signaling pathways are common in Intestinal T-cell Lymphomas (2016) (63)
- Marginal zone lymphomas in children and the young adult population; characterization of genetic aberrations by FISH and RT-PCR (2010) (63)
- Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report (2009) (63)
- Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis. (2006) (62)
- EBV May Be Expressed in the LP Cells of Nodular Lymphocyte–predominant Hodgkin Lymphoma (NLPHL) in Both Children and Adults (2014) (62)
- Hyperactivated PI3Kδ promotes self and commensal reactivity at the expense of optimal humoral immunity (2018) (61)
- Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients (2016) (61)
- Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis. (2003) (61)
- The histological classification of diffuse large B-cell lymphomas. (2015) (60)
- IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion (2019) (60)
- Gall Bladder and Extrahepatic Bile Duct Lymphomas: Clinicopathological Observations and Biological Implications (2010) (60)
- Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival. (2013) (59)
- Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea. (2017) (59)
- Nodal Involvement by Cutaneous CD30-positive T-cell Lymphoma Mimicking Classical Hodgkin Lymphoma (2012) (58)
- Aberrant type 1 immunity drives susceptibility to mucosal fungal infections (2021) (58)
- BCL6 gene rearrangements also occur in marginal zone B‐cell lymphoma (1997) (58)
- Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL. (2017) (58)
- Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma (2005) (58)
- Fibrin-associated EBV-positive Large B-Cell Lymphoma: An Indolent Neoplasm With Features Distinct From Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation (2017) (57)
- C/EBPβ expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway (2010) (57)
- Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency. (2012) (56)
- Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma. (2020) (56)
- Platelets amplify endotheliopathy in COVID-19 (2021) (56)
- EBV-Related Lymphoproliferative Disease Complicating Therapy with the Anti-CD2 Monoclonal Antibody, Siplizumab, in Patients with T-Cell Malignancies (2009) (55)
- Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome. (2009) (55)
- End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making (2018) (54)
- NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphoma. (2006) (54)
- Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases (2017) (53)
- Abnormal B-cell maturation in the bone marrow of patients with germline mutations in PIK3CD. (2017) (53)
- Plerixafor for the Treatment of WHIM Syndrome (2019) (53)
- Subcutaneous panniculitis‐like T‐cell lymphoma in the pediatric age group: A lymphoma of low malignant potential (2013) (52)
- Cytokine receptor signaling is required for the survival of ALK− anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations (2017) (52)
- Overexpression of T-bet in HIV infection is associated with accumulation of B cells outside germinal centers and poor affinity maturation (2019) (52)
- Romidepsin in peripheral and cutaneous T‐cell lymphoma: mechanistic implications from clinical and correlative data (2015) (52)
- Prognostic significance of bone marrow trephine and peripheral blood smears in 55 patients with mantle cell lymphoma. (1996) (52)
- Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome: a case report (2020) (51)
- Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors. (2005) (50)
- Primary Cutaneous CD30-Positive Anaplastic Large Cell Lymphoma in Childhood: Report of 4 Cases and Review of the Literature (2005) (50)
- Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease. (2019) (50)
- Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma. (2004) (50)
- EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features (2017) (49)
- Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers. (2016) (49)
- Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib. (2020) (49)
- BCL‐6 EXPRESSION IN REACTIVE LYMPHOID TISSUE AND IN B‐CELL NON‐HODGKIN'S LYMPHOMAS (1996) (49)
- Follicular lymphomas with plasmacytic differentiation include two subtypes (2010) (49)
- Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcoma. (2007) (48)
- Primary CNS T-cell Lymphomas: A Clinical, Morphologic, Immunophenotypic, and Molecular Analysis (2015) (47)
- Primary Mediastinal Large B-Cell Lymphoma, Classic Hodgkin Lymphoma Presenting in the Mediastinum, and Mediastinal Gray Zone Lymphoma: What is the Oncologist To Do? (2011) (47)
- Early lymphoid lesions: conceptual, diagnostic and clinical challenges (2014) (47)
- Primary lymphoma of the liver in a patient with acquired immune deficiency syndrome and chronic hepatitis B. (1989) (46)
- Anti-tumor activities of the angiogenesis inhibitors interferon-inducible protein-10 and the calreticulin fragment vasostatin (2002) (46)
- 90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin’s lymphoma (2015) (46)
- Clonal Epstein-Barr virus in lymphoepithelioma-like carcinoma of the stomach: demonstration of viral genome by in situ hybridization and Southern blot analysis. (1992) (45)
- Gray Zone Lymphoma: Better Treated Like Hodgkin Lymphoma or Mediastinal Large B-Cell Lymphoma? (2012) (45)
- Activated platelet–T-cell conjugates in peripheral blood of patients with HIV infection: coupling coagulation/inflammation and T cells (2015) (43)
- Lymph node histology in typical and atypical chronic lymphocytic leukemia. (1998) (43)
- IgG4‐related disease presenting as recurrent mastoiditis (2012) (43)
- Blastic variant of mantle cell lymphoma shows a heterogenous pattern of somatic mutations of the rearranged immunoglobulin heavy chain variable genes (1998) (42)
- Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups (2019) (41)
- Expression of the Interferon Regulatory Factor 8/ICSBP-1 in Human Reactive Lymphoid Tissues and B-cell Lymphomas: A Novel Germinal Center Marker (2008) (41)
- Marginal zone B-cell lymphomas including mucosa-associated lymphoid tissue type lymphoma (MALT), monocytoid B-cell lymphoma and splenic marginal zone cell lymphoma and their relation to the reactive marginal zone. (1997) (41)
- CD5+ follicular lymphoma: a clinicopathologic study of three cases. (2002) (41)
- Fluorescence in situ hybridization identifies new chromosomal changes involving 3q27 in non‐Hodgkin's lymphomas with BCL6/LAZ3 rearrangement (1995) (40)
- Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease. (2010) (40)
- Development of T3/T cell receptor gene expression in human pre-T neoplasms. (1987) (39)
- Integrated Single-Cell Atlases Reveal an Oral SARS-CoV-2 Infection and Transmission Axis (2020) (39)
- Human herpesvirus-6-associated acute lymphadenitis in immunocompetent adults (2004) (38)
- Human PI3Kγ deficiency and its microbiota-dependent mouse model reveal immunodeficiency and tissue immunopathology (2019) (38)
- PD-1 Blockade in Mediastinal Gray-Zone Lymphoma. (2017) (38)
- Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand. (2011) (38)
- Paraganglioma of cauda equina. A report of a case and review of the literature (1983) (36)
- Limited diversity and selection of rearranged gamma genes in polyclonal T cells. (1987) (34)
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma With Atypical T Cells: A Morphologic Variant Mimicking Peripheral T-Cell Lymphoma (2011) (34)
- Expression of c-myc and c-fms oncogenes in trophoblastic cells in hydatidiform mole and normal human placenta. (1993) (34)
- The Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 Modulates Chronic Active BCR Signaling and Induces Tumor Regression in Relapsed/Refractory ABC DLBCL (2011) (32)
- Lymphocytic vasculitis involving the central nervous system occurs in patients with X‐linked lymphoproliferative disease in the absence of Epstein–Barr virus infection (2009) (31)
- Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in Caucasians. (2019) (31)
- Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1–Associated Adult T-cell Leukemia/lymphoma (2016) (31)
- Latent sites of Epstein-Barr virus infection. (1993) (30)
- High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma (2020) (30)
- Phase I Study of Dose-Adjusted-Teddi-R with Ibrutinib in Untreated and Relapsed/Refractory Primary CNS Lymphoma (2015) (29)
- Detection of clonal Epstein-Barr virus in malignant proliferation of peripheral blood CD3+ CD8+ T cells. (1992) (29)
- STAT5B: A Differential Regulator of the Life and Death of CD4+ Effector Memory T Cells (2018) (29)
- Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting (2019) (29)
- MDM2 antagonist Nutlin-3 enhances bortezomib-mediated mitochondrial apoptosis in TP53-mutated mantle cell lymphoma. (2010) (29)
- Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. (2013) (28)
- B-Cell Lymphoma in a Patient with Complete Interferon Gamma Receptor 1 Deficiency (2013) (28)
- Loss of the proteins Bak and Bax prevents apoptosis mediated by histone deacetylase inhibitors (2013) (27)
- Discordant bone marrow involvement in non-Hodgkin lymphoma. (2016) (27)
- Recurrent somatic JAK3 mutations in NK-cell enteropathy. (2019) (27)
- T Cells Expressing a Novel Fully-Human Anti-CD19 Chimeric Antigen Receptor Induce Remissions of Advanced Lymphoma in a First-in-Humans Clinical Trial (2016) (27)
- Translocation of bcl‐2 gene in non‐Hodgkin's lymphomas in Hong Kong Chinese (1990) (26)
- T‐cell rich B‐cell lymphoma: a morphological variant of a variety of non‐Hodgkin's lymphomas or a clinicopathological entity? (1995) (26)
- Primary Mediastinal Large B-Cell Lymphoma (PMBL) Outcome May Be Significantly Improved by the Addition of Rituximab to Dose-Adjusted (DA)-EPOCH and Obviates the Need for Radiation: Results from a Prospective Study of 44 Patients. (2006) (26)
- Aberrations of MYC are a common event in B-cell prolymphocytic leukemia. (2014) (26)
- IL2RG Reversion Event in a Common Lymphoid Progenitor Leads to Delayed Diagnosis and Milder Phenotype (2015) (26)
- KSHV-associated and EBV-associated Germinotropic Lymphoproliferative Disorder: New Findings and Review of the Literature. (2017) (26)
- Late-Onset Severe Chronic Active EBV in a Patient for Five Years with Mutations in STXBP2 (MUNC18-2) and PRF1 (Perforin 1) (2015) (26)
- Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: A case report (2019) (25)
- Expanding the Spectrum of EBV-positive Marginal Zone Lymphomas: A Lesion Associated With Diverse Immunodeficiency Settings (2018) (24)
- Phase I/II study of Bortezomib Alone and Bortezomib with Dose-Adjusted EPOCH Chemotherapy in Relapsed or Refractory Aggressive B-Cell Lymphoma. (2004) (24)
- Epstein-Barr virus-associated inflammatory pseudotumor presenting as a colonic mass. (2015) (24)
- Nodal and Extranodal Plasmacytomas Expressing Immunoglobulin A: An Indolent Lymphoproliferative Disorder With a Low Risk of Clinical Progression (2010) (23)
- Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti–programed death-ligand 1 (Avelumab) (2016) (23)
- The clinicopathologic spectrum of mature aggressive B cell lymphomas (2017) (23)
- Clinically occult Leydig cell tumor presenting with gynecomastia. (1989) (23)
- CD15‐expressing nodular lymphocyte‐predominant Hodgkin lymphoma (2011) (22)
- Phase II trial of dose-adjusted EPOCH in untreated systemic anaplastic large cell lymphoma (2016) (22)
- Chronic active Epstein-Barr virus infection: a novel cause of lymphocytic variant hypereosinophilic syndrome. (2013) (22)
- Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia (2018) (21)
- CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma (2020) (21)
- Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases. (2021) (21)
- Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1 (2015) (21)
- Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation. (2012) (21)
- Coexisting and Clonally Identical Classic Hodgkin Lymphoma and Nodular Lymphocyte Predominant Hodgkin Lymphoma (2011) (21)
- OA18.03 Safety and Clinical Activity of Avelumab (MSB0010718C; Anti-PD-L1) in Patients with Advanced Thymic Epithelial Tumors (TETs) (2017) (21)
- Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET (2017) (20)
- The genetic landscape of dural marginal zone lymphomas (2016) (20)
- Primary Mediastinal Large B-Cell Lymphoma (PMBL) Outcome Is Significantly Improved by the Addition of Rituximab to Dose Adjusted (DA)-EPOCH and Overcomes the Need for Radiation. (2005) (20)
- CD40 agonist antibody mediated improvement of chronic Cryptosporidium infection in patients with X-linked hyper IgM syndrome. (2012) (20)
- Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies (2021) (19)
- Rhesus iPSC Safe Harbor Gene-Editing Platform for Stable Expression of Transgenes in Differentiated Cells of All Germ Layers. (2017) (19)
- Phase 1 study of combination rituximab with apolizumab in relapsed/refractory B-cell lymphoma and chronic lymphocytic leukemia (2005) (19)
- Epstein Barr Virus in Carcinoma of the Cervix (1993) (19)
- Granulomatous reaction in Burkitt lymphoma: correlation with EBV positivity and clinical outcome. (2005) (19)
- Primary diffuse large B cell lymphoma of the stomach: analysis of somatic mutations in the rearranged immunoglobulin heavy chain variable genes indicates antigen selection (1999) (18)
- A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice (2022) (18)
- Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation (2017) (18)
- Phase I study of an antitumor vaccination using α(1,3) galactosyltransferase expressing allogeneic tumor cells in patients (Pts) with refractory or recurrent non-small cell lung cancer (NSCLC) (2005) (18)
- Concurrent Expression Of MYC/BCL2 Protein In Newly Diagnosed DLBCL Is Not Associated With An Inferior Survival Following EPOCH-R Therapy (2013) (17)
- Novel Treatment of Burkitt Lymphoma with Dose-Adjusted EPOCH-Rituximab: Preliminary Results Showing Excellent Outcome. (2006) (17)
- Immune Characteristics Associated with Lymphomatoid Granulomatosis and Outcome Following Treatment with Interferon-Alpha (2010) (17)
- Genomic Profiling for Clinical Decision Making in Lymphoid Neoplasms. (2022) (17)
- Pathobiology of T-cell and NK-cell lymphomas. (2013) (17)
- ALK-positive histiocytosis with KIF5B-ALK fusion in an adult female (2019) (17)
- The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy (2020) (17)
- Circulating Tumor DNA Dynamics during Therapy Predict Outcomes in Mantle Cell Lymphoma (2018) (16)
- A study of PD‐L1 expression in intravascular large B cell lymphoma: correlation with clinical and pathological features (2019) (15)
- Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma. (2020) (15)
- Novel markers in pediatric-type follicular lymphoma (2019) (15)
- A Pilot Trial of Campath-1H and Dose-Adjusted EPOCH in CD52-Expressing Aggressive T-Cell Malignancies. (2005) (15)
- Viral-associated lymphoid proliferations. (2013) (14)
- Adult T-cell leukemia/lymphoma with Epstein-Barr virus-positive Hodgkin-like cells. (2011) (14)
- Aspergillosis, eosinophilic esophagitis, and allergic rhinitis in signal transducer and activator of transcription 3 haploinsufficiency. (2018) (14)
- Treatment of HIV-associated Primary CNS Lymphoma with Antiretroviral Therapy, Rituximab, and High-Dose Methotrexate. (2020) (14)
- Comparative Clinical and Biological Features of Primary Mediastinal B-Cell Lymphoma (PMBL) and Mediastinal Grey Zone Lymphoma (MGZL). (2009) (14)
- FAB classification of myelodysplastic syndromes: merits and controversies (1995) (14)
- Efficacy and toxicity of dose-adjusted EPOCH-rituximab in adults with newly diagnosed Burkitt lymphoma (2007) (13)
- A 17-year old patient with DOCK8 deficiency, severe oral HSV-1 and aggressive periodontitis - a case of virally induced periodontitis? (2015) (13)
- MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R (2018) (13)
- Safety and clinical activity of anti-programmed death-ligand 1 (PD-L1) antibody (ab) avelumab (MSB0010718C) in advanced thymic epithelial tumors (TETs). (2016) (13)
- Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape (2020) (12)
- Phase 1b/2 Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory B-Cell Lymphoma: Safety, Efficacy and Molecular Analysis (2020) (12)
- Expansion of PD1-positive T Cells in Nodal Marginal Zone Lymphoma (2019) (12)
- Chapter 1 – Classification and Histopathology of the Lymphomas (2006) (12)
- Small B cell NHL and their leukemic counterpart: differences in subtyping and assessment of leukemic spread. (1996) (11)
- Bone marrow trephines. Findings in patients with hairy cell leukaemia before and after treatment (1994) (11)
- In Vitro Culture During Retroviral Transduction Improves Thymic Repopulation and Output After Total Body Irradiation and Autologous Peripheral Blood Progenitor Cell Transplantation in Rhesus Macaques (2006) (11)
- Stable T3- and T3+ subclones derived from the mosaic human T cell leukemia cell line, CEM. (1988) (11)
- DOCK 8 Deficiency, EBV+ Lymphomatoid Granulomatosis, and Intrafamilial Variation in Presentation (2017) (11)
- Liver disturbances in activated phosphoinositide 3-kinase δ syndrome. (2018) (11)
- Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma (2017) (11)
- Abbreviated Treatment with Short-Course Dose-Adjusted EPOCH and Rituximab (DA-EPOCH-R) Is Highly Effective in AIDS-Related Lymphoma (ARL). (2004) (11)
- Pathologic Findings in NEMO Deficiency: A Surgical and Autopsy Survey (2015) (11)
- Bortezomib + DA-EPOCH-R Induction Therapy Followed by Maintenance Bortezomib Versus Observation in Newly Diagnosed Mantle Cell Lymphoma (2012) (11)
- MDM2 Antagonist Nutlin-3 Enhances Bortezomib-Mediated Mitochondrial Apoptosis In TP53-Mutated Mantle Cell Lymphoma (2010) (11)
- The Association Between Carcinoma Of The Tonsil And Epstein‐Barr Virus — A Study Using Radiolabelled In Situ Hybridization (1994) (11)
- Monitoring of Circulating Tumor DNA As Minimal Residual Disease in Diffuse Large B-Cell Lymphoma (2014) (10)
- Mantle-cell lymphoma. (1994) (10)
- Accelerated calcific degeneration of a bovine pericardial valve in an adolescent. (1982) (10)
- Haploinsufficiency of immune checkpoint receptor CTLA4 induces a distinct neuroinflammatory disorder. (2020) (10)
- Gray Zone Lymphomas: Clinical and Histological Characteristics and Treatment with Dose-Adjusted-EPOCH-R (2008) (9)
- A Druggable TCF4 and BRD4 Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (2016) (9)
- EBV-Related Lymphoproliferative Disease Complicating Therapy with Siplizumab, a Novel Anti-CD2 Mediated T- and NK-Cell Depleting Agent, in Patients with T-Cell Malignancies. (2007) (9)
- Dose-Adjusted EPOCH-Rituximab Is Highly Effective in the GCB and ABC Subtypes of Untreated Diffuse Large B-Cell Lymphoma. (2004) (9)
- A multiprotein supercomplex controlling oncogenic signalling in lymphoma (2018) (9)
- Philadelphia‐like translocation t(9;22)(q34;q11) found in a follicular lymphoma involving not BCR and ABL but IGL‐mediated rearrangement of an unknown gene on 9q34 (1997) (9)
- Compromised counterselection by FAS creates an aggressive subtype of germinal center lymphoma (2020) (9)
- Case Report: Severe Rhabdomyolysis and Multiorgan Failure After ChAdOx1 nCoV-19 Vaccination (2022) (8)
- Yttrium-90 Radiolabeled Humanized Monoclonal Antibody to CD25 in Refractory and Relapsed Hodgkin’s Lymphoma (2008) (8)
- Cutaneous barrier leakage and gut inflammation drive skin disease in Omenn syndrome (2020) (8)
- Siglec-6 is a Target for Chimeric Antigen Receptor T-cell Treatment of Chronic Lymphocytic Leukemia (2021) (8)
- Pulmonary Manifestations of the Autoimmune Lymphoproliferative Syndrome. A Retrospective Study of a Unique Patient Cohort. (2016) (8)
- Disseminated and Congenital Toxoplasmosis in a Mother and Child With Activated PI3-Kinase δ Syndrome Type 2 (APDS2): Case Report and a Literature Review of Toxoplasma Infections in Primary Immunodeficiencies (2019) (8)
- Partial RAG deficiency in humans induces dysregulated peripheral lymphocyte development and humoral tolerance defect with accumulation of T-bet+ B cells (2022) (8)
- DA-EPOCH-R Is Highly Effective in Both BCL-6+ and BCL-6− Untreated De Novo Diffuse Large B-Cell Lymphoma (DLBCL): Study Update and Analysis of Survival Outcomes for Multiple Biomarkers. (2006) (8)
- DA-EPOCH Chemotherapy Is Highly Effective in ALK-Positive and ALK-Negative ALCL: Results of a Prospective Study of PTCL Subtypes in Adults (2011) (8)
- Different gastritis features are linked to different gastric neoplasms. (1999) (8)
- Phase I/II study of a hybrid schedule of flavopiridol in relapsed/refractory mantle cell lymphoma (MCL) and diffuse large B-cell lymphoma (DLBCL). (2016) (8)
- Peripheral T-cell lymphoma with aberrant expression of CD30, CD15, and CD20. (2011) (8)
- Evidence of SARS-CoV-2-Specific T-Cell-Mediated Myocarditis in a MIS-A Case (2021) (8)
- Evidence for collagen fibrils inside the cells of granular cell myoblastomas. (1980) (8)
- Correlates of Lenalidomide Induced Immune Stimulation and Response in CLL: Analysis in Patients on Treatment (2011) (7)
- Walker BA, Mavrommatis K, Wardell CP, et al. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma. Blood. 2018;132(6):587-597. (2018) (7)
- Autoimmune pancreatitis in the autoimmune lymphoproliferative syndrome (ALPS): a sheep in wolves' clothing? (2013) (7)
- Benralizumab completely depletes gastrointestinal tissue eosinophils and improves symptoms in eosinophilic GI disease. (2022) (7)
- Increased CD5‐positive polyclonal B cells in Castleman disease: a diagnostic pitfall (2013) (7)
- PNMZL and PTFL: morphological variants with a common molecular profile - a unifying hypothesis. (2022) (7)
- Dose-Adjusted Teddi-R Induces Durable Complete Remissions in Relapsed and Refractory Primary CNS Lymphoma (2018) (7)
- Long-Term Outcome of AIDS-Related Lymphoma Treated with Abbreviated Cycles of EPOCH-RR: A Prospective Study of 40 Patients (2008) (7)
- Circulating tumor DNA to predict timing of relapse in mantle cell lymphoma. (2018) (7)
- Multicentric Castleman disease and the evolution of the concept (2021) (7)
- Phase II Study of Interferon-Alpha and DA-EPOCH+/-R in Lymphomatoid Granulomatosis (2018) (7)
- Author response: Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI (2017) (7)
- Phase I/II study of Yttrium-90 labeled humanized anti-Tac (HAT) monoclonal antibody and calcium DTPA in CD25-expressing malignancies (2006) (6)
- The Role of the Microenvironment for CLL Proliferation and Survival: Gene Expression Profiling of Leukemic Cells Derived from Blood, Bone Marrow and Lymph Nodes Reveals the B-Cell Receptor and NF κB as Dominant Signaling Pathways (2008) (6)
- Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomas (2019) (6)
- Preliminary Results of a Response-Adapted Study of Ibrutinib and Isavuconazole with Temozolomide, Etoposide, Liposomal Doxorubicin, Dexamethasone, Rituximab (TEDDI-R) for Secondary CNS Lymphoma (2020) (6)
- MDM 2 Antagonist Nutlin-3 Displays Antiproliferative and Proapoptotic Activity in Mantle Cell Lymphoma (2009) (6)
- CRISPR/Cas9‐mediated introduction of the sodium/iodide symporter gene enables noninvasive in vivo tracking of induced pluripotent stem cell‐derived cardiomyocytes (2020) (6)
- Clinical anti-lymphoma activity and toxicity of T cells expressing a novel anti-CD19 chimeric antigen receptor with fully-human variable regions. (2018) (6)
- DA-EPOCH-R in Primary Mediastinal B-Cell Lymphoma; Analysis of End of Therapy FDG-PET and Outcome (2016) (6)
- Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma (2021) (6)
- Lost in translation: Lack of CD4 expression due to a novel genetic defect. (2021) (6)
- Neutrophil and Eosinophil Extracellular Traps in Hodgkin Lymphoma (2021) (6)
- 90Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's Lymphoma. (2020) (5)
- Splenic marginal zone lymphoma - Response (1996) (5)
- CHARACTERIZATION OF THE GENETIC LANDSCAPE OF HIGH‐GRADE B‐CELL LYMPHOMA, NOS – AN LLMPP PROJECT (2021) (5)
- Next-generation sequencing–based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL (2021) (5)
- Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma (2022) (5)
- Variable Bruton Tyrosine Kinase (BTK) Resynthesis across Patients with Chronic Lymphocytic Leukemia (CLL) on Acalabrutinib Therapy Affect Target Occupancy and Reactivation of B-Cell Receptor (BCR) Signaling (2018) (5)
- Epstein-Barr Virus-negative Marginal Zone Lymphoma as an Uncommon Form of Monomorphic Posttransplant Lymphoproliferative Disorder (2020) (5)
- Re-evaluating TTF-1 immunohistochemistry in diffuse gliomas: Expression is clone-dependent and associated with tumor location. (2017) (5)
- Undifferentiated neuroendocrine (Merkel cell) carcinoma of the salivary glands. A light and electron microscopic study of two cases (1983) (5)
- Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas (2018) (5)
- A Multi-scale, Multiomic Atlas of Human Normal and Follicular Lymphoma Lymph Nodes (2022) (4)
- Phase 1 Study of Escalating Doses of Ibrutinib and Temozolomide, Etoposide, Liposomal Doxorubicin, Dexamethasone, Rituximab (TEDDI-R) with Isavuconazole for Relapsed and Refractory Primary CNS Lymphoma (2020) (4)
- Age related EBV associated lymphoproliferative disorder – a spectrum of reactive lymphoid hyperplasia and lymphoma : The Western experience (2011) (4)
- Classical Hodgkin Lymphoma Arising Adjacent to a Breast Implant (2016) (4)
- Human Herpes Virus 6 (HHV-6)–associated Lymphadenitis: Pitfalls in Diagnosis in Benign and Malignant Settings (2018) (4)
- Comparative Study of Circulating Tumor DNA and Computerized Tomography Monitoring in Untreated Diffuse Large B-Cell Lymphoma (2015) (4)
- Evidence of SARS-CoV-2-Specific T-Cell-Mediated Myocarditis in a MIS-A Case (2021) (4)
- Human Dectin-1 deficiency impairs macrophage-mediated defense against phaeohyphomycosis (2022) (4)
- Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas (2021) (4)
- Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy syndrome (2022) (4)
- Keratinocyte Growth Factor Increases Thymic Output of Naïve T-Cells after Total Body Irradiation and Autologous Peripheral Blood Progenitor Cell Transplantation in Rhesus Macaques. (2005) (4)
- Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab (2009) (4)
- Constitutive Activation of AKT Contributes to the Pathogenesis and Survival of Blastoid Variants of Mantle Cell Lymphoma. (2005) (4)
- Into the gray-zone: update on the diagnosis and classification of a rare lymphoma (2019) (4)
- Sudden death presenting as massive haemoptysis due to ruptured intrapulmonary aortic aneurysm. (1993) (4)
- Late-Onset Severe Chronic Active EBV in a Patient for Five Years with Mutations in STXBP2 (MUNC18-2) and PRF1 (Perforin 1) (2015) (3)
- Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphoma. (2022) (3)
- Distinct Human and Viral Interleukin-6 Profiles and Other Viral and Immunologic Abnormalities In KSHV-Associated Multicentric Castleman Disease: Relationship with Disease Activity and Individual Disease Manifestations (2011) (3)
- B-cell lymphomas with discordance between pathological features and clinical behavior (2017) (3)
- Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD) (2010) (3)
- Lenalidomide Induced Cytokine Release Syndrome in Chronic Lymphocytic Leukemia (CLL): Clinical and Laboratory Correlates of Immune Activation. (2008) (3)
- Phase 1b Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory B-Cell Lymphoma: Safety, Efficacy and Molecular Analysis (2019) (3)
- A morphometric and ultrastructural study of the long term effect of portacaval anastomosis on the liver of normal male rats. (1983) (3)
- Further considerations on the Revised European-American Lymphoma classification. (1996) (3)
- Comparative Gene Expression Profiling of Leukemia Cells in Peripheral Blood and Tissue Compartments Reveals a Prominent Role of the Microenvironment for CLL Cell Proliferation. (2009) (3)
- CCND1 Genomic Rearrangement as a Secondary Event in High Grade B-Cell Lymphoma (2020) (3)
- A novel approach for characterization of KSHV‐associated multicentric Castleman disease from effusions (2022) (3)
- Abstract LB-141: Potent single agent activity of Ibrutinib (PCI-32765) in patients with chronic lymphocytic leukemia (CLL): clinical and translational results from an ongoing phase II study. (2013) (3)
- Response to Comments on “Aberrant type 1 immunity drives susceptibility to mucosal fungal infections” (2021) (3)
- Hodgkin Lymphoma Variant of Richter Transformation: Morphology, EBV Status, Clonality and Survival Analysis a Retrospective Study of 77 Patients (2015) (3)
- A Prospective Study of Clonal Evolution in Follicular Lymphoma: Circulating Tumor DNA Correlates with Overall Tumor Burden and Fluctuates over Time without Therapy (2021) (3)
- End-of-Treatment CT and Serial FDG-PET Imaging to Assess Residual Disease in Primary Mediastinal B-Cell Lymphoma (2017) (3)
- The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia (2022) (3)
- Inflammatory Cytokines, Hyperferritinemia and IgE Are Prognostic in Patients with KSHV-Associated Lymphomas Treated with Curative Intent Therapy (2014) (3)
- Gene Expression Profiling Reveals The Lymph Node Microenvironment As a Niche For BCR Engagement, NFκB Pathway Activation, and Tumor Proliferation In Mantle Cell Lymphoma (2013) (3)
- Serum free light chains as predictors of lymphomagenesis in patients with autosomal dominant hyper-immunoglobulin E syndrome (Job's syndrome) (2013) (3)
- DNA Sequencing-Based Monitoring Of Serum Predicts Clinical Relapse Before CT Imaging in Diffuse Large B-Cell Lymphoma (2013) (3)
- ALK-1 antibody staining pattern in anaplastic large cell lymphoma (ALCL) and ALCL-Hodgkin's like (1997) (2)
- Dermatofibrosarcoma protuberans (DFSP) in six patients with ADA-SCID. (2016) (2)
- Phase I Study of Lenalidomide Combined with Dose-Adjusted EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma in Participants with or without HIV (NCT02911142) (2020) (2)
- Radiation-Sparing Treatment of HIV-Related Primary Central Nervous System Lymphoma with Antiretroviral Therapy, Rituximab and High-Dose Methotrexate (2018) (2)
- Prolonged Complete Response in a Pediatric Patient With Primary Peripheral T-Cell Lymphoma of the Central Nervous System (2015) (2)
- Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition. (2022) (2)
- Alemtuzumab (Campath 1-H) in Patients with HTLV-1 Associated Adult T-Cell Leukemia/Lymphoma. (2008) (2)
- IFNγR1 deficiency presenting with visceral leishmaniasis and Mycobacterium Avium infections mimicking HLH (2021) (2)
- Presentation and Pathogenesis of B-Cell Lymphoid Cancers Associated with HIV Infection (2014) (2)
- 387. Myeloid Sarcoma Associated with Gene Marking of Hematopoietic Stem Cells in a Rhesus Macaque (2005) (2)
- Multifactorial regulation of the human c-myc oncogene. (1988) (2)
- Identification of a Subset of Peripheral T-Cell Lymphoma, Not Otherwise Specified, Characterized By FOXP3-Positive Regulatory T-Cell Phenotype, HTLV-1 Negativity and Poor Outcome (2014) (2)
- PHASE 1B STUDY OF ViPOR (VENETOCLAX, IBRUTINIB, PREDNISONE, OBINUTUZUMAB, LENALIDOMIDE) IN RELAPSED/REFRACTORY B‐CELL LYMPHOMA: SAFETY, EFFICACY AND MOLECULAR ANALYSIS (2019) (2)
- In Vitro Culture during Retroviral Transduction Improves Thymic Repopulation and Output after TBI and Autologous PBPC Transplantation in Rhesus Macaques. (2004) (2)
- Down-Regulation of Promyelocytic Cell Transferrin Receptor Expression by Cholera Toxin and Cyclic Adenosine Monophosphate (1986) (2)
- The Addition of Rituximab to Dose-Adjusted EPOCH with HAART Suspension Is Highly Effective and Tolerable in AIDS-Related Lymphoma (ARL) and Allows the Delivery of Abbreviated Chemotherapy. (2005) (2)
- A phase II study of ibrutinib and short‐course fludarabine in previously untreated patients with chronic lymphocytic leukemia (2020) (2)
- subtypes of diffuse large B-cell lymphoma Differential efficacy of bortezomib plus chemotherapy within molecular (2013) (2)
- Phase 2 Study of Acalabrutinib Window Prior to Frontline Therapy in Untreated Aggressive B-Cell Lymphoma: Preliminary Results and Correlatives of Response to Acalabrutinib (2021) (2)
- Expanding Spectrum of Malignancies in ALPS: A Cancer Predisposing Syndrome?. (2012) (2)
- Image Gallery: Primary cutaneous Rosai–Dorfman disease (2019) (2)
- Yttrium-90 Radiolabeled Daclizumab, An Anti-CD25 Monoclonal Antibody, Provides Effective Therapy for Refractory and Relapsed Hodgkin's Lymphoma, (2011) (2)
- FDG-PET as a Marker of tumor proliferation Compared to Gene-Expression Proliferation Scores, MIB1%, and LDH In Untreated Mantle Cell Lymphoma (MCL) (2010) (2)
- Richter transformation to Hodgkin lymphoma on Bruton’s tyrosine kinase inhibitor therapy (2018) (2)
- Phase 1b/2 Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory and Untreated Mantle Cell Lymphoma: Safety, Efficacy, and Molecular Analysis (2021) (2)
- Phase I and pharmacokinetic study of sorafenib in Kaposi sarcoma. (2013) (2)
- Kaposi sarcoma herpesvirus (KSHV)-associated lymphomas are associated with markedly elevated serum IL-10, elevated IL-6, IL-17 and circulating KSHV (2012) (2)
- Endemic Burkitt Lymphoma in second-degree relatives in Northern Uganda: in-depth genome-wide analysis suggests clues about genetic susceptibility (2020) (1)
- Methylation Profiling of Mediastinal Gray Zone Lymphoma Reveals a Distinctive Signature with Elements Shared by Classical Hodgkin's Lymphoma and Mediastinal Large B-Cell Lymphoma (2010) (1)
- 90 Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin’s Lymphoma (2020) (1)
- Treatment Outcomes and Prognostic Factors in 40 Patients with Primary Effusion Lymphoma (2021) (1)
- PI3K a Selective Inhibitor Induces Growth Inhibition In Mantle Cell Lymphoma (2010) (1)
- 18F-FDG PET Imaging Features of Patients With Autoimmune Lymphoproliferative Syndrome. (2019) (1)
- The MDM2 Antagonist Nutlin-3 Is Lethal to Mantle Cell Lymphoma with Wild Type p53. (2007) (1)
- Follicle Center Lymphoma (FCL) of the Lower Female Genital Tract (LFGT) (2022) (1)
- The transcription factor CCAAT/enhancer binding protein (C/EBP)beta is constitutively expressed in ALK-positive anaplastic large cell lymphomas (ALCL), and is dependent upon NPM-ALK kinase activity (2006) (1)
- Clinical, Immunologic, and Virologic Findings in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Lymphomas Suggest KSHV-Associated Inflammatory Syndromes Contribute to Symptoms and Disease Pathogenesis. (2012) (1)
- A patient with Fever and rash. (2014) (1)
- New cytogenetic findings and their correlation with histology in marginal zone B-cell lymphoma (1995) (1)
- Constitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver fibrosis syndrome (2022) (1)
- Treatment and biology of lymphomatoid granulomatosis (2007) (1)
- Malignancy in STAT3 Deficient Hyper IgE Syndrome (2022) (1)
- Second cancers early post allogeneic transplant: the case of ‘unrestrained’ malignancy? (2013) (1)
- Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children (2022) (1)
- THE MUTATIONAL LANDSCAPE OF DOUBLE/TRIPLE‐HIT HIGH‐GRADE B‐CELL LYMPHOMA WITH BCL2 REARRANGEMENT (DH/TH‐ BCL2 ) – AN LLMPP PROJECT (2021) (1)
- disease: a 28-year experience in the United States Characterization and treatment of chronic active Epstein-Barr virus (2011) (1)
- Robust, persistent adaptive immune responses to SARS-CoV-2 in the oropharyngeal lymphoid tissue of children (2022) (1)
- Chapter 73 – The Pathologic Basis for the Classification of Non-Hodgkin and Hodgkin Lymphomas (2018) (1)
- Mutation analysis of rearranged heavy chain variable (IgH V) genes in gastrointestinal diffuse large B-cell lymphoma indicates positive antigen selection of the neoplastic cells (1997) (1)
- Rapid Emergence of T Follicular Helper and Germinal Center B Cells Following Antiretroviral Therapy in Advanced HIV Disease (2021) (1)
- Kaposi sarcoma herpesvirus (KSHV)-associated lymphomas are associated with markedly elevated serum IL-10, elevated IL-6, IL-17 and circulating KSHV (2012) (1)
- The Genomic Landscape of Plasmablastic Lymphoma (PBL) - an L.L.M.P.P. Project (2021) (1)
- A Phase II Trial of Alemtuzumab (Campath) with DA-EPOCH-R in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma (2012) (1)
- Adult T-cell leukemia/lymphoma with EBV-positive Hodgkin-like cells (2011) (1)
- Chromosomal gains and losses in marginal zone B-cell lymphoma detected by comparative genomic hybridization (1996) (1)
- A Prospective Multicenter Phase 2 Study of Dose-Adjusted-EPOCH-R in Untreated MYC-Rearranged Aggressive B-cell Lymphoma (2019) (1)
- KSHV activation, human and viral IL-6 production, and other cytokine dysregulation: Association with the symptomatology of KSHV-associated multicentric Castleman’s disease (2010) (1)
- Nasopharyngeal carcinoma [3] (1992) (1)
- Abstract 11039: Platelets Contribute to Disease Severity in Covid-19 (2021) (1)
- B-Cell Maturation Antigen Is a Promising Target for Genetically-Modified T-Cell Therapy of Multiple Myeloma (2012) (1)
- X-linked polymorphism of hypoxanthine phosphoribosyl transferase gene (HPRT) in Chinese females. (1992) (1)
- Molecular insights into the pathogenesis of follicular lymphoma (2021) (1)
- The outcome of ALK positive and ALK negative anaplastic large cell lymphoma (ALCL) following DA-EPOCH. (2015) (1)
- BCL6 gene rearrangements occur also in marginal zone B-cell lymphoma (1997) (1)
- Bortezomib plus DA-EPOCH-rituximab followed by bortezomib maintenance versus observation in previously untreated mantle cell lymphoma (MCL). (2011) (1)
- follow-up in a unique case series mimicking intestinal lymphoma: clinicopathologic features and NK-cell enteropathy: a benign NK-cell lymphoproliferative disease (2011) (1)
- Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma (2021) (1)
- Clinicopathologic and Molecular Characterization of Epstein-Barr Virus–positive Plasmacytoma (2022) (1)
- Hyperactivated PI3Kδ promotes self and commensal reactivity at the expense of optimal humoral immunity (2018) (1)
- Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial. (2023) (1)
- Preliminary Results from a Phase II Study of Response-Adapted Therapy with Copanlisib and Rituximab for Untreated Follicular Lymphoma (2020) (1)
- Early Results of a Clinical Trial Using Targeted Oncolytic Virotherapy in Kaposi Sarcoma Herpes Virus (KSHV) Associated Multicentric Castleman’s Disease (MCD). (2007) (1)
- Protracted course of disseminated adenovirus disease with necrotizing granulomas in the liver. (2019) (1)
- syndrome with the CXCR4 antagonist plerixafor A phase 1 clinical trial of long-term, low-dose treatment of WHIM (2014) (1)
- Commentary on “Pathologic Diagnosis of Mantle Cell Lymphoma” (2000) (1)
- A Phase I/II Study of a Hybrid Schedule of Flavopiridol in Relapsed/Refractory Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma (2010) (1)
- Distal Equine Anti-Thymocyte Globulin (ATG) As an Adjunct to Reduced Intensity Conditioning and Posttransplantation Cyclophosphamide (PTCy) for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Benign and Malignant Disorders of T Cell Proliferation or Dysregulation (2021) (1)
- Lymphoid hyperplasia with atypical dendritic/Langerhans cell proliferation mimicking Hodgkin lymphoma (2019) (1)
- Pilot Study of Radiation-Targeted Donor Lymphocyte Infusion for Cancer Progression after Allogeneic Hematopoietic Stem Cell Transplantation (2015) (1)
- 18F-FDG PET Imaging Features of Patients With Autoimmune Lymphoproliferative Syndrome. (2019) (1)
- Congenital B cell lymphocytosis linked to a novel germline CARD11 mutation (109.13) (2012) (0)
- Title Expression of c-myc and c-fms oncogenes in trophoblastic cellsin hydatidiform mole and normal human placenta (2004) (0)
- Hemophagocytosis and coagulopathy associated with cutaneous γ‐δ T‐cell lymphoma (2004) (0)
- A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency (2023) (0)
- Chromosomal aberrations in gray zone lymphomas (2011) (0)
- Gene Expression Profiling Reveals a Crucial Role for C/EBPbeta in Proliferation Pathways of ALK+ ALCL Cell Lines (2008) (0)
- BCL-6 gene expression by immunohistochemistry in normal lymphoid tissue and B-cell non-Hodgkin' s lymphomas with and without BCL-6 rearrangement (1994) (0)
- Detection of 2p23/ALK abnormalities in anaplastic large cell lymphomas (ALCL) by cytogenetic, FISH and immunohistochemistry (1997) (0)
- FISH detection of IG lambda mediated chromosomal translocations in B-cell malignancies (1998) (0)
- 77 – Lymphomas including Hodgkin lymphoma (2008) (0)
- Abstract PO-22: Compromised counterselection by FAS creates a lethal subtype of germinal center lymphoma (2020) (0)
- Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide (ViPOR) in Relapsed and Refractory Follicular Lymphoma: Analysis of Safety, Efficacy, and Minimal Residual Disease (2022) (0)
- Chronic EBV Infection Through NKG 2 D Regulates Cytotoxic Functions of NK and CD 8 T Cells in 2 + Mg (2013) (0)
- Mantle cell lymphoma a well defined clinico-pathological entity associated with t(11;14)(q13;q32) translocation (1994) (0)
- Interim results of a clinical trial using oncolytic virotherapy in Kaposi's sarcoma-associated herpesvirus (KSHV) associated-Multicentric Castleman's Disease (MCD) (2009) (0)
- P184 CTLA-4 haploinsufficiency presenting as acute myelitis due to nonmalignant lymphocytic infiltration of the spinal cord (2016) (0)
- 527. Improvement of Pre-Clinical Non-Human Primate Model for Pluripotent Stem Cell Based Therapies by Introducing Marker Genes in Safe Harbor Locus (2016) (0)
- Abnormal B-Cell Maturation Pattern in the Bone Marrow of Patients with Germline Mutations in PIK3CD (2014) (0)
- Preliminary results of a clinical trial using chemo-immunotherapy in Kaposi sarcoma herpesvirus (KSHV)-associated multicentric Castleman’s disease (MCD) (2008) (0)
- Detection of residual hairy cell leukemia after 2-CdA treatment in routinely processed trephine sections using the IGH CD3 polymerase chain reaction technique (1996) (0)
- C/EBPβ Expression in ALK+ Anaplastic Large Cell Lymphomas (ALCL) Is Regulated by Stat3 Signaling Pathway. (2007) (0)
- PL3-5 A novel role of IL-22R1 as a possible driver of inflammation in ALK+ anaplastic large cell lymphoma (2010) (0)
- Phase 1 Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide in Combination with Polatuzumab (ViPOR-P) in Relapsed/Refractory B-Cell Lymphoma: Preliminary Analysis of Safety and Efficacy (2022) (0)
- [Ultrastructural studies in the differential diagnosis of some non-Hodgkin's lymphatic neoplasms]. (1979) (0)
- Abstract 2423: Phase I/II study of antitumor vaccination using lung cancer cells expressing murine α(1,3)galactosyltransferase (αGT) in non-small cell lung cancer (NSCLC) (2010) (0)
- Mutational Status of Chronic Lymphocytic Leukemia (CLL) Determines Clonlal Evolution in Classical Hodgkin’s Lymphoma Variant of Richter’s Transformation. (2005) (0)
- Histological characteristic of bone marrow trephines in myelodysplastic syndromes (1994) (0)
- Efficacy of alemtuzumab (ALZ) in combination with dose-adjusted EPOCH (DA-EPOCH) in untreated nodal peripheral T-cell lymphoma (PTCL). (2012) (0)
- Kaposi sarcoma herpesvirus viral load as a biomarker for leptomeningeal involvement by primary effusion lymphoma. (2022) (0)
- chemokine stromal-derived factor-1 Regulation of endothelial cell branching morphogenesis by endogenous (2013) (0)
- Immunohistochemistry for the Hematopathology Laboratory (2011) (0)
- B-Cell Lymphoma in a Patient with Complete Interferon Gamma Receptor 1 Deficiency (2013) (0)
- PEDIATRIC NODAL MARGINAL ZONE LYMPHOMA AND PEDIATRIC-TYPE FOLLICULAR LYMPHOMA SHARE A COMMON MOLECULAR PROFILE (2022) (0)
- Abstract LB-281: Hodgkin Lymphoma requires stabilized NIK and constitutive RelB expression for survival (2012) (0)
- anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease Molecular characterization of the t(2;5) (p23; q35) translocation in (2011) (0)
- survival of mantle cell lymphoma Constitutive activation of Akt contributes to the pathogenesis and (2013) (0)
- Lymphoproliferative Disorders in Primary Immune Deficiencies (2019) (0)
- EBV-associated inflammatory pseudotumor presenting as a colonic mass (2015) (0)
- Failure in Patients with Advanced Malignancy A Pilot Study of CTLA-4 Blockade after Cancer Vaccine (2007) (0)
- List of Contributors (2019) (0)
- Identification of Genes Which Play a Crucial Role in C/EBPβ Downstream Signalling in ALK+ ALCL Cell Lines. (2009) (0)
- capture microdissection In situ localization of follicular lymphoma: description and analysis by laser (2013) (0)
- Nasopharyngeal carcinoma. (1992) (0)
- University of Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics (2012) (0)
- Marginal zone B-cell lymphoma: characterization by cytogenetics and fluorescence in situ hybridization (FISH) (1996) (0)
- Evaluation of bone marrow trephine involvement in mantle cell lymphoma: by morphology, phenotyping and PCR (1996) (0)
- FDG-PET SUV Correlates with Expression of Genes Reflecting Proliferation, Metabolism, and Oncogene Activity in Mantle Cell Lymphoma (MCL), (2011) (0)
- Immunotherapy of Lymphomatoid Granulomatosis (2022) (0)
- Diffuse large B-cell lymphoma includes at least three distinct clinicopathologic entities (1996) (0)
- clone sarcomas: evidence for transdifferentiation of the follicular lymphoma Clonally related follicular lymphomas and histiocytic/dendritic cell (2013) (0)
- Transient Responses and Significant Toxicities Due to Cytopenias and Rashes with Anti-CD30 CAR T Cells for CD30-Expressing Lymphomas: Results of a Phase I Clinical Trial (2022) (0)
- Clinical Spectrum of RAS-Associated Autoimmune Leukoproliferative Disorder (RALD): A Distinct Clinical Entity Mimicking Juvenile Myelomonocytioc Leukemia (JMML) or Chronic Myelomonocytic Leukemia (CMML) (2012) (0)
- Abstract 109: Platelets Amplify Endotheliopathy In Covid-19 (2021) (0)
- hematopoietic progenitor cells in a rhesus macaque Acute myeloid leukemia is associated with retroviral gene transfer to (2014) (0)
- Integration and Iteration: Using Advanced, High-Content Imaging and Single-Cell Gene Expression Analysis to Uncover Unique Aspects of Follicular Lymphoma Biology (2020) (0)
- interleukin-12 for AIDS-related Kaposi's sarcoma Phase II study of pegylated liposomal doxorubicin in combination with (2013) (0)
- [Presence of intracellular collagen fibrils in systemic lymph node neoplasms]. (1980) (0)
- Publisher Correction: Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma (2022) (0)
- 359 Tumoh markers in thyroid nodules (1983) (0)
- undefined autoimmune lymphoproliferative syndrome mutations are common in patients with genetically FAS Somatic (2012) (0)
- Dermatofibrosarcoma Protuberans in 3 Patients with ADA-SCID (2008) (0)
- Massive hemorrhagic necrosis of the spinal cord in metastatic cord compression. (1983) (0)
- IL2RG Reversion Event in a Common Lymphoid Progenitor Leads to Delayed Diagnosis and Milder Phenotype (2015) (0)
- Transfusion medicine illustrated. Hemophagocytosis and coagulopathy associated with cutaneous gamma-delta T-cell lymphoma. (2004) (0)
- WHIM Syndrome Cured by Chromothripsis (2015) (0)
- A Constitutivly Active NFkB Non Canonical Pathway Is Maintained by RelB Repression of TRAF2 to Prevent Autophagy-Mediated Cell Death in Hodgkin Lymphomas (2011) (0)
- B CELL DISORDER CLASSIFICATION AND SUSCEPTIBITY TO INHIBITORS (2018) (0)
- ‘A novel approach for characterisation of KSHV‐associated multicentric Castleman disease from effusions’: Response (2023) (0)
- Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in ATG9A (2022) (0)
- A bivalent EBV vaccine induces neutralizing antibodies that block B and epithelial cell infection and confer immunity in humanized mice (2022) (0)
- THE TOPOLOGY OF MYC REARRANGEMENTS IN DOUBLE‐HIT LYMPHOMA IS CONSTRAINED BY THE PRECEDING IGH ‐BCL2 REARRANGEMENT – AN LLMPP PROJECT (2021) (0)
- Non-Hodgkin's lymphomas presenting at diagnosis with large spleen or splenic lymphomas (1994) (0)
- Characterization of 22 cases of marginal zone B-cell lymphoma with trisomy 3 (1996) (0)
- Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder (2022) (0)
- [Optical and ultrastructural diagnostic criteria in lymph-node reticulosarcomas]. (1980) (0)
- Reduced-intensity allogeneic stem cell transplantation for diffuse large B-cell lymphoma: Clinical evidence of a graft-versus-lymphoma effect. (2006) (0)
- Clinical, Biochemical, and Radiographic Responses to Rituximab Combined with Liposomal Doxorubicin (R-Dox) in HIV-Infected Patients with Severe Kaposi Sarcoma-Associated Herpes Virus (KSHV) – Associated Multicentric Castleman's Disease. (2009) (0)
- Phase 2 Study of Alemtuzumab Added to Dose-Adjusted EPOCH-R in Relapsed and Refractory Aggressive B-Cell Lymphomas (2019) (0)
- CLL 369 SIGNAL TRANSDUCTION IN CHRONIC LYMPHOCYTIC LEUKEMIA ( CLL ) CELLS BY MULTIPARAMETER FLOW-CYTOMETRY (2008) (0)
- Malignancy in STAT3 Deficient Hyper IgE Syndrome (2022) (0)
- TheMonoclonal Antibody ALK1Identifies a Distinct Morphological Subtype ofAnaplastic LargeCell LymphomaAssociated with2p23IALK Rearrangements (1997) (0)
- A phase I study of antitumor vaccination using tumor cells genetically modified to express alpha(1,3)galactosyltransferase (αGT) in patients with refractory or recurrent non-small cell lung cancer (NSCLC). (2006) (0)
- Errata (2002) (0)
- Gray Zone Lymphoma (GZL) with Features Intermediate between Diffuse Large B-Cell Lymphoma (DLBCL) and Classical Hodgkin Lymphoma (cHL): A Pathologic Consensus Study with Patient Outcomes and Prognostication across 15 North American Centers (2017) (0)
- Histopathology and SARS-CoV-2 Cellular Localization in Eye Tissues of COVID-19 Autopsies (2023) (0)
- Abstract 193: CRISPR-mediated Introduction of the Sodium-iodide Symporter to Enable Non-invasive Monitoring of Macaque Induced-pluripotent Stem Cell-derived Cardiomyocytes (2017) (0)
- Hodgkin Lymphomas – Historical Background And Evolution (2019) (0)
- Gray Zone Lymphoma (GZL) with Features Intermediate Between Diffuse Large B-Cell Lymphoma (DLBCL) and Classical Hodgkin Lymphoma (cHL): Pathologic Classification and Clinical Outcomes from a Multicenter Consensus Study (2016) (0)
- macaques autologous hematopoietic progenitor cell transplantation in rhesus Keratinocyte growth factor augments immune reconstitution after (2013) (0)
- Abbreviated Treatment with EPOCH-Rituximab and HAART Suspension Is Highly Effective in AIDS-Related Lymphoma (ARL). (2006) (0)
- Phase II Study of Pegylated Liposomal Doxorubicin in Combination with Interleukin-12 for AIDS-Related Kaposi’s Sarcoma Running head: IL-12 AND LIPOSOMAL DOXORUBICIN FOR KAPOSI’S SARCOMA (2007) (0)
- Correction: Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET (2018) (0)
- Quantitative Baseline Circulating Tumor DNA Levels Correlate with GM-CSF Response to Idiotype Vaccine in Untreated Mantle Cell Lymphoma (2016) (0)
- Different molecular consequences of a t(9;22)(q34;q11) in CML and NHL (1996) (0)
- Splenic marginal zone lymphoma. Response (Response to Isaacson ) (1996) (0)
- Mutations in PIK3CD Can Cause Hyper IgM Syndrome (HIGM) Associated with Increased Cancer Susceptibility (2014) (0)
- Inhibition of Immunoglobulin Secretion, But Not Immunoglobulin Synthesis, by a Monoclonal Antibody (1986) (0)
- Author Correction to: Endemic Burkitt lymphoma in second-degree relatives in Northern Uganda: in-depth genome-wide analysis suggests clues about genetic susceptibility (2021) (0)
- bc1-2 translocation in malignant lymphomas in hong kong chinese (1990) (0)
- Correction to: Malignancy in STAT3 Deficient Hyper IgE Syndrome (2022) (0)
- of mantle cell lymphoma Constitutive activation of Akt contributes to the pathogenesis and survival (2013) (0)
- Diffuse large B-cell lymphoma: does subgrouping correlates with specific cytogenetic findings ? (1996) (0)
- Ongoing Activation of the BCR, NFκB, and Proliferation Pathways in Mantle Cell Lymphoma: Direct in Vivo Evidence for the Role of the Lymph Node Microenvironnment (2014) (0)
- 1133. A Phase I Study of Antitumor Vaccination Using Genetically Modified Tumor Cells Expressing |[alpha]|(1,3)Galactosyltransferase in Patients with Refractory or Recurrent Non-Small Cell Lung Cancer (NSCLC): Preliminary Results (2005) (0)
- The Functional Immunophenotypic Profile of Kikuchi Fujimoto Disease: Comparison with Systemic Lupus Erythematosus (2022) (0)
- Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome: a case report (2020) (0)
- PTEN Regulates SYK-Directed AKT Activation in MCL. (2009) (0)
- A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile (2022) (0)
- F.3. Somatic Mosaicism for STAT3 Mutation Unveils Critical Role in Human T-cell Memory Development and B Cell Help (2009) (0)
- Patient characteristics of 4 children with anaplastic large cell lymphoma (ALCL) associated with a translocation T(2;5) (P23;Q35) and anaplastic lymphoma kinase (ALK) expression (1997) (0)
- Late-onset enteric virus infection associated with hepatitis (EVAH) in transplanted SCID patients. (2023) (0)
- Response-Adapted Therapy in HIV-Associated Diffuse Large B-Cell Lymphoma: Updated Results of a Prospective Phase II Study of Short-Course-EPOCH-RR (2019) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Stefania Pittaluga?
Stefania Pittaluga is affiliated with the following schools:
